DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Phenytek is a drug marketed by Mylan and is included in one NDA.
The generic ingredient in PHENYTEK is phenytoin sodium. There are twenty-one drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the phenytoin sodium profile page.
A generic version of PHENYTEK was approved as phenytoin sodium by WEST-WARD PHARMS INT on December 31st, 1969.
Pharmacology for PHENYTEK
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Mylan||PHENYTEK||phenytoin sodium||CAPSULE;ORAL||040298-002||Dec 6, 2001||AB||RX||No||No||Start Trial||Start Trial||Start Trial|
|Mylan||PHENYTEK||phenytoin sodium||CAPSULE;ORAL||040298-003||Dec 6, 2001||AB||RX||No||Yes||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|